We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Whitehawk Therapeutics (Nasdaq: WHWK), formerly Aadi Bioscience, has officially rebranded to reflect its transformation into ...

New option listings for March 19th include Colombier Acquisition Corp II (CLBR), Danimer Scientific, Inc. (DNMRQ), Kalaris Therapeutic Inc.

New name reflects focus on accelerating portfolio of advanced ADC therapies with speed, agility and precision Upon closing of strategic transactions, cash expected ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

**NM signifies a non meaningful value. A dash signifies the data is not available.

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments.